KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intuitive Surgical (ISRG) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Intuitive Surgical (ISRG) over the last 17 years, with Q4 2025 value amounting to $203.3 million.

  • Intuitive Surgical's Share-based Compensation rose 1485.88% to $203.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $788.2 million, marking a year-over-year increase of 1645.98%. This contributed to the annual value of $788.2 million for FY2025, which is 1645.98% up from last year.
  • Intuitive Surgical's Share-based Compensation amounted to $203.3 million in Q4 2025, which was up 1485.88% from $203.5 million recorded in Q3 2025.
  • Intuitive Surgical's Share-based Compensation's 5-year high stood at $203.5 million during Q3 2025, with a 5-year trough of $103.2 million in Q1 2021.
  • Moreover, its 5-year median value for Share-based Compensation was $148.4 million (2023), whereas its average is $151.0 million.
  • In the last 5 years, Intuitive Surgical's Share-based Compensation soared by 831.92% in 2022 and then skyrocketed by 2080.89% in 2025.
  • Intuitive Surgical's Share-based Compensation (Quarter) stood at $117.8 million in 2021, then rose by 8.32% to $127.6 million in 2022, then grew by 17.87% to $150.4 million in 2023, then rose by 17.69% to $177.0 million in 2024, then grew by 14.86% to $203.3 million in 2025.
  • Its Share-based Compensation stands at $203.3 million for Q4 2025, versus $203.5 million for Q3 2025 and $196.2 million for Q2 2025.